Amgen Anakinra Arthritis Advisory Committee Review Expected In August
Amgen expects an advisory committee review of its rheumatoid arthritis treatment anakinra in August.
Amgen expects an advisory committee review of its rheumatoid arthritis treatment anakinra in August.